TrialBlood cancer discovery2026

Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.

Jayastu Senapati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.